Audiological Disturbances in Vitiligo

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Information provided by:
Hadassah Medical Organization Identifier:
First received: June 7, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted

The purpose of this study is to determine wether vitiligo patients have more audiological abmnormalities, than the healthy population.

Hearing Loss

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional

Resource links provided by NLM:

Further study details as provided by Hadassah Medical Organization:


Ages Eligible for Study:   3 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • vitligo patients under 50. healthy patients under 50 for control group

Exclusion Criteria:

  • above age 50. systemic disease. exposure to loud noise in past. familial history of deafness use of autotoxuc drugs or steroids. autoimmune/metabolic/neurologic/vascular disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00484224

Contact: Arieh Ingber, Prof. 972 2 6776366

Hadassah Medical Organization Not yet recruiting
Jerusalem, Israel
Sponsors and Collaborators
Hadassah Medical Organization
Principal Investigator: Arieh Ingber, Prof. Hadassah Medical Organization
  More Information

Publications: Identifier: NCT00484224     History of Changes
Other Study ID Numbers: qwer1234-HMO-CTIL
Study First Received: June 7, 2007
Last Updated: June 7, 2007
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Hearing Loss
Ear Diseases
Hearing Disorders
Nervous System Diseases
Neurologic Manifestations
Otorhinolaryngologic Diseases
Pigmentation Disorders
Sensation Disorders
Signs and Symptoms
Skin Diseases processed this record on October 07, 2015